Brigade Sapeurs-Pompiers Paris
- Address
- 1, place Jules Renard, BP 31, cedex17, 75823 Paris, France
Brigade Sapeurs-Pompiers Paris - Emergency Cardiac Care Research
Brigade Sapeurs-Pompiers Paris (Paris Fire Brigade) operates as a specialized emergency medical research center with particular expertise in pre-hospital acute cardiac care. The center focuses on advancing emergency interventions for time-critical cardiovascular conditions, conducting clinical trials that bridge the gap between initial emergency response and definitive hospital treatment.
- ST-segment elevation myocardial infarction (STEMI) treatment protocols
- Pre-hospital pharmacological interventions for acute coronary syndromes
- Emergency antiplatelet therapy and bleeding risk assessment
The center's research program emphasizes optimizing outcomes for patients experiencing acute myocardial infarction by evaluating novel therapeutic agents administered in the critical pre-hospital phase. Their trials assess both efficacy in improving 30-day clinical outcomes and safety profiles, particularly monitoring bleeding complications according to established criteria such as GUSTO and BARC classifications. This unique focus on the emergency medical services setting positions the center at the forefront of developing rapid-response cardiac interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Brigade Sapeurs-Pompiers Paris
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized, Placebo-Controlled Study on the Efficacy and Safety of Zalunfiban in Pre-Hospital ST-Elevation Myocardial Infarction Patients | Celecor Therapeutics Inc. | Phase III | Not Recruiting | Apr 2021 | May 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Zalunfiban | 1 | Unknown | 2021-04-22 | 2021-04-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
